NHS 的早期试验表明，2-OHOA（一种从油酸中提取的“橄榄油药物”）通过重构癌细胞膜来治疗胶质母细胞瘤具有良好的效果。 NHS early trials indicate promising results for 2-OHOA, an "olive oil drug" derived from oleic acid, in treating glioblastoma by reconfiguring cancerous cell membranes.
NHS 的早期试验表明，一种从油酸中提取的“橄榄油药物”有望治疗胶质母细胞瘤，这是一种致命且无法治愈的脑肿瘤。 NHS early trials show promise for an "olive oil drug" derived from oleic acid in treating glioblastoma, a deadly and incurable form of brain tumor. 这种药物被称为 2-OHOA，可以重新配置癌细胞膜以防止肿瘤生长或扩散。 The drug, known as 2-OHOA, reconfigures cancerous cell membranes to prevent tumor growth or spread. 第三阶段试验正在进行中，如果成功，它可以为脑肿瘤和其他癌症提供新的治疗选择。 A phase three trial is underway, and if successful, it could offer new treatment options for brain tumors and other cancers.